Stay updated on Deucravacitinib Safety Efficacy in UC Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Safety Efficacy in UC Clinical Trial page.

Latest updates to the Deucravacitinib Safety Efficacy in UC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check93 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
- Check100 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Deucravacitinib Safety Efficacy in UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety Efficacy in UC Clinical Trial page.